FDA, Sponsors Advance Reliance on Real-World Data & Evidence
October 1, 2021 Jill Wechsler, Pharm Exec’s Washington Correspondent Demand for more efficient and faster development of medical products is prompting regulatory authorities to incorporate additional sources of information into research and approval processes, notably data provided by patient registries and medical records able to inform traditional clinical trials. FDA…